We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of ICPT yet.

ICPT Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2023, worth a combined $0 — down 100% from $725M a quarter earlier.

Sellers outnumbered buyers: 146 funds closed out of ICPT and 0 opened new positions — a net loss of 146 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $78.1M sold.

  • 0 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2023, down from 146 in Q3 2023.
  • Funds reported $0 of Intercept Pharmaceuticals, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2023 and 146 closed out, a net change of -146 holders.
  • The largest Intercept Pharmaceuticals, Inc. seller in Q4 2023 was BlackRock, an estimated $78.1M sold.

Based on aggregated 13F filings for Q4 2023.